GHENT, Belgium--(BUSINESS WIRE)--Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that it will present highlights from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback